Memorandum from Richard S. Schwartz, Cutter, to M. Sternberg, re Analysis of Proposal from National Heart/Lung Blood Institute for Study of Safety of Heat-Treated Factor VIII Concentrates in the Treatment of Hemophiliacs, and letter from L. Barbosa, Department of Health & Human Services, to Steven Ojala, Cutter Laboratories, attaching proposed initiative titled, Safety of Heat-treated Factor VIII Concentrates in the Treatment of Hemophiliacs.